Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-01-26
|
emixustat |
macular atrophy secondary to Stargardt disease |
2 |
Acucela (USA - MA) |
Rare diseases - Genetic diseases - Ophtalmological diseases |
2017-01-25
|
relugolix |
heavy menstrual bleeding associated with uterine fibroids |
3 |
Myovant Sciences (Switzerland) |
Women health |
2017-01-25
|
BGB-3111 |
Waldenström’s macroglobulinemia |
3 |
BeiGene (China) |
Cancer - Oncology |
2017-01-25
|
ABBV-8E12/C2N-8E12 |
Alzheimer's Disease |
2 |
Abbvie (USA - IL) |
Neurodegenerative diseases |
2017-01-25
|
ABBV-8E12/C2N-8E12 |
progressive supranuclear palsy |
2 |
AbbVie |
Rare diseases - Neurodegenerative diseases - Neurological diseases |
2017-01-25
|
IFN alpha Kinoid |
type 1 diabetes |
preclinical |
Neovacs (France) |
Autoimmune diseases - Metabolic diseases |
2017-01-24
|
resminostat (oral pan-histone deacetylase (HDAC) inhibitor) |
hepatocellular carcinoma (HCC) |
2 |
Yakult Honsha (Japan) 4SC (Germany) |
Cancer - Oncology |
2017-01-24
|
TPIV 200 (multi-epitope folate receptor alpha peptide vaccine with GM-CSF adjuvant) and durvalumab |
ovarian cancer |
2 |
Memorial Sloan Kettering Cancer Center (USA - NY) AstraZeneca (UK) Tapimmune (USA - Fl) |
Cancer - Oncology |
2017-01-23
|
Vectibix® (panitumumab) |
chemorefractory wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC)/p> |
3 |
Amgen (USA - CA) |
Cancer - Oncology |
2017-01-23
|
CAR T-cell therapy |
|
preclinical |
Cellectis (France) |
|
2017-01-20
|
CA4P (fosbretabulin tromethamine) |
unresectable, recurrent or metastatic pancreatic or gastrointestinal neuroendocrine tumors |
2 |
Mateon Therapeutics (USA - CA), previously known as Oxigene (USA - CA) |
Cancer - Oncology |
2017-01-20
|
IPI-549 |
|
preclinical |
Infinity Pharmaceuticals (USA - MA) |
Cancer - Oncology |
2017-01-20
|
IMP321 |
metastatic breast cancer |
2b |
Prima Biomed (Australia) |
Cancer - Oncology |
2017-01-19
|
Cimzia® (certolizumab pegol) |
psoriasis |
3 |
UCB (Belgium) |
Autoimmune diseases - Dermatological diseases |
2017-01-19
|
Opdivo® (nivolumab) |
gastric cancer |
3 |
Ono Pharmaceutical (Japan) BMS (USA - NY) |
Cancer - Oncology |
2017-01-18
|
GBT440 |
sickle cell disease |
3 |
Global Blood Therapeutics (USA - CA) |
Rare diseases - Genetic diseases - Hematological diseases |
2017-01-18
|
GX-G6 |
type 2 diabetes |
1 |
Genexine (Republic of Korea) |
Metabolic diseases |
2017-01-17
|
SFX-01 |
breast cancer |
1-2 |
Evgen Pharma (UK) |
Cancer - Oncology |
2017-01-17
|
ulipristal acetate |
uterine fibroids |
3 |
Gedeon Richter (Hungary) Allergan (Ireland) |
Gynecology - Women's health |
2017-01-17
|
Xilonix™ |
advanced colorectal cancer |
3 |
XBiotech (USA - TX) |
Cancer - Oncology |